Scancell Holdings PLC (SCLP.L) – Market Performance Overview
- Stock Price – As of 05:19 AM Central Europe on Thursday 22 October 2026, Scancell traded down 90 % in a 24‑hour period.
- Current Price – Approximately GBX 90.2 on major exchanges.
- Shares Outstanding – 12.1 million.
- Market Capitalisation – GBX 149.1 million.
- Volume (last 24 h) – Roughly GBX 14 million worth of shares were traded.
Recent Trend
- Month‑End Change – The share price has declined 90.51 % since the previous month’s end.
- Moving Average – The simple moving average over the last 200 days is GBX 134.14.
- 52‑Week Range – The highest price recorded was GBX 295 on 19 May 2026; the lowest was GBX 9.24 on 20 October 2026.
Comparison with Peer Companies (Last 24 h)
| Company | Ticker | % Change | Current Price | Market Capitalisation | Additional Metrics |
|---|---|---|---|---|---|
| Cornish Metals | TIN.L | –41.18 % | GBX 60 | GBX 170.3 mn | — |
| Beeks Cloud | BKS.L | +1.98 % | GBX 190 | GBX 163 mn | P/E = 38.8 |
| Mercia Asset Management | MERC.L | –1.61 % | GBX 30.5 | GBX 175.3 mn | — |
| Ct Managed Portfolio | CMPI.L | 0 % | GBX 130.5 | GBX 124.2 mn | — |
| Macfarlane | MACF.L | +2.12 % | GBX 80.9 | GBX 164.6 mn | P/E = 20.71 |
Company Overview
Scancell Holdings PLC is a London‑based biotechnology firm that develops vaccines utilizing a human monoclonal antibody platform. The company’s technology allows for customisation of vaccines to target specific diseases. Scancell is listed on the London Stock Exchange and provides further information on its website at www.scancell.co.uk .
